Vanda Pharmaceuticals, Inc. (VNDA) Misses Q1 Views
Tweet
Share
E-mailGet Alerts VNDA Hot Sheet
Price: $5.13 +0.39%
EPS Growth %: -60.5%
Financial Fact:
Product sales: 38.48M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -60.5%
Financial Fact:
Product sales: 38.48M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) reported Q1 EPS of ($0.28), $0.12 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $8.14 million versus the consensus estimate of $8.3 million.
For earnings history and earnings-related data on Vanda Pharmaceuticals, Inc. (VNDA) click here.
For earnings history and earnings-related data on Vanda Pharmaceuticals, Inc. (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Lumentum shares rise on analyst upgrades, AI demand outlook
- DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
